Jet Capital Investors’s GSK GSK Stock Holding History

Jet Capital Investors’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-908,000	Closed	-$49.4M	–	17
2022 Q2	$49.4M	Buy	908,000 +800,000	+741%	+$44.2M	16.06%	1
2022 Q1	$5.88M	Buy	+108,000	New	+$5.87M	0.92%	25

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Jet Capital Investors's GSK Position: Q2 2022 in Review

Jet Capital Investors sold out of GSK (GSK) in Q2 2022, closing a stake of 508,000 shares — an estimated $28M sold.

Jet Capital Investors first reported a position in GSK in Q3 2021 and held it in 3 quarters. The position peaked at $27.7M in Q1 2022. 901 funds tracked by Wall St. Rank hold GSK as of Q2 2022.

Jet Capital Investors reported no remaining GSK position as of Q2 2022 after selling out during the quarter.
Jet Capital Investors sold 508,000 GSK shares in Q2 2022, an estimated $28M.
Jet Capital Investors first reported a position in GSK in Q3 2021 and held it in 3 quarters.
Jet Capital Investors's GSK position peaked at $27.7M in Q1 2022.
901 funds tracked by Wall St. Rank held GSK as of Q2 2022.

Based on Jet Capital Investors's 13F filing for Q2 2022, filed 15 Aug 2022.